Since we observed that STYK1 knockdown did not alter PI3K or MAPK activation in NSCLC cells, it is unlikely that the classical FGFR-dependent signaling pathways are involved in the mechanism we identified. Here, STYK1 is linked to non-small cell lung carcinoma.